Our Pediatric Bone Marrow Transplant unit is a one-of-a-kind subdivision of the Pediatric Hemato-Oncology Department. We perform approximately 25 pediatric transplants annually. Our skilled physicians conduct both autologous transplants (taken from the patient’s own stem cells) to treat solid tumors, as well as allogeneic transplants (using donor tissue) to treat conditions such as metabolic diseases, leukemia, immunodeficiencies, and other hematologic disorders. When necessary, we work with the National Marrow Donor Program to locate suitable tissue donors, and we also use a modern HLA laboratory to evaluate bone marrow for suitability.
At our Solid and Brain Tumor Research Laboratory, we are actively engaged in research to explore new treatments for pediatric cancer patients. Numerous projects are ongoing, including investigations into the genetic markers of pediatric brain cancer, stem cell research, and various drug therapies for brain cancer.